BioSpace News Archive

The concept of company culture is a hot topic in the workplace now. Here are some tips to help you be more likable during an interview.

4D pharma plc, a pharmaceutical company focusing on the development of Live Biotherapeutics, announced that data from the completed Phase Ib clinical study of Thetanix® for the treatment of Crohn’s disease will be presented on 18 May in a poster session at the 2019 Digestive Disease Week meeting in San Diego.

Takeda Pharmaceutical Company Limited and the London School of Hygiene & Tropical Medicine will announce at the evening reception, hosted by the Embassy of Japan in the United Kingdom, the establishment of the Takeda Chair in Global Child Health, endowed by a £3 million donation by Takeda to LSHTM.

Nordic Nanovector ASA announces that it will report its first quarter 2019 results on Thursday, 23 May 2019.

Alligator Bioscience today announces that the outline of the ongoing Phase I study with the bispecific drug candidate ATOR-1015 will be showcased at the American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago on May 31- June 4, 2019.

Medivir AB today informs that new data from the phase I study of birinapant in combination with pembrolizumab (Keytruda®) will be presented during the American Society of Clinical Oncology annual meeting, which will take place 31 May – 04 June in Chicago, USA.

Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S.

EyeArt® AI Screening System Automatically Identifies Referable Diabetic Retinopathy in Patients with Diabetes, Improving Patient Compliance and Saving Vision

Recipients from the US and Netherlands will be recognized in Marburg, Germany on Friday, 24 May

ImaginAb Inc., a clinical stage immuno-oncology imaging company, announces it has enrolled its first patient for the Phase II clinical trial of its lead product, CD8 tracer 89Zr-Df-IAB22M2C, at City of Hope in Los Angeles County.